In addition, CD133+ glioblastoma CSCs have also been discovered to secrete TGF-β, which directly downregulates the NKG2D expression level and facilitates avoidance of cellular lysis (Figure 2) [156,157]. Here, TGFB1 is linked to glioblastoma.